According to Zhitong Finance App, Dongyang Pharmaceutical (06887.HK) issued an announcement. The board of directors was notified by Mr. Zhang Yushuai, the controlling shareholder and non-executive director of the company, that he intends to purchase the company's shares listed on the Hong Kong Stock Exchange Limited on the open market through him or through an entity controlled by him, thereby increasing the company's shares. Mr. Cheung plans to increase his share holdings worth between HK$30 billion and HK$600 million over the next six months through him or through the entities he controls. In the future, Mr. Zhang will increase the amount of his holdings through him or through his controlled entities as appropriate according to market conditions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.